Nuclear receptor subfamily 1 group I member 3 Inhibitors (IC50, Ki)

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	Clotrimazole	IC50	80.0 [1], 100.0 [2], 690.0 [3]
	Clotrimazole	Ki	100.0 [1]
	Ethinyl estradiol	IC50	3000.0 [1]
	1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide	IC50	390.0 [1]
	Tiracizine	IC50	4078.0 [1]
	Androstanol	IC50	1200.0 [1]
	Propan-2-yl N-[11-[3-(diethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	6400.0 [1]
	Ethyl 5-(N,N-dimethyl-beta-alanyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-3-ylcarbamate	IC50	5010.0 [1]
	Ethyl N-[11-[3-(diethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	2430.0 [1]
	Carbamic acid, (5-((ethylamino)acetyl)-10,11-dihydro-5H-dibenz(b,f)azepin-3-yl)-, ethyl ester	IC50	24490.0 [1]
	Carbamic acid, (5-(aminoacetyl)-10,11-dihydro-5H-dibenz(b,f)azepin-3-yl)-, ethyl ester	IC50	70000.0 [1]
	Cinpa1	IC50	687.0 [1]
	CID 1069342	IC50	235.0 [1]
	Ethyl N-[11-(3-morpholin-4-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	320.0 [1]
	Ethyl N-[11-[2-(4-methylpiperazin-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	38755.0 [1]
	Ethyl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	210.0 [1]
	Propan-2-yl N-[11-(2-piperidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	249.0 [1]
	Propan-2-yl N-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	680.0 [1]
	CID 1129891	IC50	620.0 [1]
	Propan-2-yl N-[11-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	70000.0 [1]
	Methyl N-[11-(3-morpholin-4-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	288.0 [1]
	Ethyl N-[11-[2-(2,2,6,6-tetramethylpiperidin-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	4080.0 [1]
	Ethyl N-[11-[2-(7-azabicyclo[2.2.1]heptan-7-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	1410.0 [1]
	Ethyl N-[11-[2-(2,5-dioxopyrrol-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	39810.0 [1]
	Propan-2-yl N-[11-[2-(2,2-dimethylpropoxy)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	21.2 [1]
	Tert-butyl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	152.9 [1]
	Tert-butyl N-[11-(2-piperidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	216.2 [1]
	Tert-butyl N-[11-(2-propan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	116.0 [1]
	Cyclohexyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	11.7 [1]
	Propan-2-yl N-[11-(2-cyclopropyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	81.5 [1]
	Propan-2-yl N-[11-(2-cyclobutyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	37.6 [1]
	Propan-2-yl N-[11-(2-cyclopentyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	19.5 [1]
	Propan-2-yl N-[11-(2-cyclohexyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	24.1 [1]
	Tert-butyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	31.9 [1]
	Cyclopropyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	22.1 [1]
	Cyclobutyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	20.1 [1]
	Cyclopentyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	13.9 [1]
	Ethyl N-[11-(3-pyrrolidin-1-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	3180.0 [1]
	Ethyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	37.0 [1]
	Ethyl N-[11-[2-(2-methylbutan-2-ylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	2060.0 [1]
	Ethyl N-[11-[2-[(2-methylpropan-2-yl)oxy]acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	70.8 [1]
	N-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]butanamide	IC50	2320.0 [1]
	Tert-butyl N-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	1030.0 [1]
	1-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-3-ethylurea	IC50	14420.0 [1]
	1-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-3-propan-2-ylurea	IC50	4930.0 [1]
	1-Tert-butyl-3-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]urea	IC50	12970.0 [1]
	Ethyl N-[11-(2-imidazol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	6890.0 [1]
	3-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-1,1-diethylurea	IC50	13990.0 [1]
	2-(Diethylamino)-1-[2-(ethylsulfamoylamino)-5,6-dihydrobenzo[b][1]benzazepin-11-yl]ethanone	IC50	19090.0 [1]
	2-(Diethylamino)-1-[2-[(5-methyl-1,3,4-oxadiazol-2-yl)amino]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]ethanone	IC50	18790.0 [1]
	Propan-2-yl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	116.4 [1]
	Propan-2-yl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	20.9 [1]
	Propan-2-yl N-[11-(2-ethoxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	11350.0 [1]
	Propan-2-yl N-[11-(2-propan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	60.1 [1]
	Propan-2-yl N-[11-(2-butan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	35.3 [1]
	Ethyl N-[11-[2-[di(propan-2-yl)amino]acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	3050.0 [1]
	Ethyl N-[11-(2-pyrrolidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	1580.0 [1]
	Ethyl N-[11-[2-(tert-butylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	3631.0 [1]
	Propan-2-yl N-[11-[3-(dimethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate	IC50	1792.0 [1]

Entire TableStructureCompound NameStandard TypeStandard Values (in nM)

Items per page: 510All1 - 10 of 59 ⟨⟩

---

---

References

This online tool may be cited as follows

MLA	"Quest Database™ Nuclear receptor subfamily 1 group I member 3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 9 May. 2024, https://www.aatbio.com/data-sets/nuclear-receptor-subfamily-1-group-i-member-3-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2024, May 9). Quest Database™ Nuclear receptor subfamily 1 group I member 3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/nuclear-receptor-subfamily-1-group-i-member-3-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan